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ABSTRACT 
 
 
Background:  Celiac Disease (CD) an autoimmune disease triggered by gluten is 
becoming more widespread. While there has been vast improvement in 
understanding the complications having CD, they are still not fully understood. 
There has been increasing research over the last decade looking at CD and 
undesirable pregnancy outcomes. The question of whether or not undiagnosed 
CD is associated with low birth weight infants, will be addressed in this paper. 
The evidence presented by the studies included will be evaluated using GRADE. 
 
Method:  An exhaustive search of available medical literature was conducted 
using Medline, PubMed, ISI Web of Science, EBM Multifile of Review, Cochrane 
Systematic Reviews and CINHAL with the search terms: celiac disease, gluten 
intolerance and low birth weight.  
 
Results:  Three articles were found in the search and reviewed in this paper. The 
studies reviewed found that women with undiagnosed/untreated CD were at an 
increased risk of having low birth weight infants when compared to women who 
were unexposed to or without CD. The case control study found an OR of 0.91 
(95% CI 0.12-6.49) and the two population cohorts, Danish and Swedish 
reported OR of   -15g (95%: -70-41)] and -170g (95% CI: -215g, -127g, 
p<0.001)], respectively.  
 
Conclusion:  Undiagnosed maternal CD results in an increased risk of low birth 
weight infants as compared to no CD, although the exact mechanism is 
unknown.  The overall GRADE assigned to the outcome of LBW was moderate. 
 
Keywords:  Celiac Disease, Gluten Intolerance, Low Birth Weight 
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INTRODUCTION 
Background 
Celiac disease (CD), a disease that until recently was considered to be 
uncommon, effecting only children, has gained respect as a health issue 
worldwide over the last decade (Olsson, Hernell, Hornell, Lonnerg, & Ivarsson, 
2008). This disease with its long history, the first occurrence dating back to the 
years before Christ was not afforded credibility in the medical community until 
recent decades, especially in the United States. CD, also known as gluten-
sensitive enteropathy, is an immune-mediated inflammation of the small 
intestines in response to gluten or prolamines which are found in barley, wheat 
and rye. Prolamines are more specifically gliadin in wheat, secalin in rye and 
hordein in barley (Sandberg-Bennich, Dahlquist, & Kallen, 2002). Oats, while 
excluded in the gluten free (GF) diet, do not contain gluten but are significantly 
cross contaminated during growth, harvesting and milling (Norris et al., 2005).  
CD is found in individuals with the associated human leukocyte antigen (HLA) 
class II genes HLA-DQ2 and/or HLA-DQ8 haplotypes located on chromosome 
6p21. Gluten when ingested by individuals with CD results in an auto-immune 
attack on the mucosal layer of the intestines damaging the microvilli responsible 
for absorption of nutrients (Farrell, 2005).  
Serological testing for CD with antigladin antibodies (AGA) and anti-
endomysial antibodies (EMA) is relatively new and has improved the number of 
individuals with CD who are correctly diagnosed (Fasano et al., 2003). Prior to 
the development of serological testing, the only way to test for CD was an small 
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bowel intestinal biopsy. While there has been improvement in ability to test for 
the disease, the only treatment for CD is strict adherence to a GF diet.  There are 
occasionally some refractory cases of CD where the damage to the intestinal 
microvilli is not resolved by adherence to a gluten free diet. New studies are 
looking at the effects of mesalamine in these cases (Jamma et al., 2011).  
Celiac disease, in the absence of GF diet causes chronic inflammation 
along the mucosal lining of the small intestine and results in a variety of other 
health problems including malnutrition, weight loss, anemia, hypocalcemia, and 
deficiencies in folic acid, vitamin B12 and zinc (Olsson et al., 2008; & Strazi & 
Mantovani, 2000).  Unfortunately, the wide spectrum of symptoms associated 
with CD ranging from completely asymptomatic to severe adnominal pain, 
cramping, diarrhea and weight loss, make it difficult to diagnosis. This can cause 
problems for individuals unaware they have the disease and who are not 
following a GF diet.  Studies suggest that CD affects up to 1% of most of the 
world’s population but most individuals with the disease are not aware they have 
it (Olsson et al., 2008). While there is speculation as to the precise percent of the 
world’s population effected, it has been accepted that overall prevalence of CD, 
varies geographically.  It is estimated that 1:130 to 1:300 individuals in Europe or 
of European descent have the disease and it is being found in other countries 
such as Africa, South America and Asia previously thought to be free of what 
was considered to be European disease (Fasano et al., 2003). 
            As the number of individuals with CD continues to grow due to improved 
diagnostic testing, improved knowledge of the disease, and other genetic and 
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environmental factors, there has been a growing interest in research on the 
disease. There has been a particular push among researchers to look at 
undiagnosed parental celiac disease and its potential impact on unfavorable 
pregnancy outcomes or adverse risks and maternal outcomes.  With the growing 
number of individuals estimated to have CD, ensuring treatment of the disease in 
women of reproductive age might be warranted given the possible risks passed 
to the fetus. 
            These studies look at CD’s effect on infertility, spontaneous abortion or 
miscarriage, preterm birth and low birth weight (Ludvigsson, Montgomery, & 
Ekbom, 2006). Among these studies conducted, there have been three that look 
specifically at CD in pregnant women not following a GF diet and the effect on 
the birth weight of the infant. This is a systematic review of those articles to see if 
there if untreated CD does result in an increased risk of low birth weight infants.  
 
Purpose of the Study 
The purpose of this paper is to perform a systematic review of the literature on 
undiagnosed maternal celiac disease in pregnant women and the possible risk it 
poses of having low birth weight infants or very low birth weight infants using the 
Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) tool developed by the GRADE Working Group (Guyatt et al., 2008). 
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METHOD 
 
An extensive literature search was performed using Medline, PubMed, ISI 
Web of Science, EBM Multifile of Review, Cochrane Systematic Reviews and 
CINHAL. These databases were accessed through the Pacific University Library 
system. The keywords searched included “celiac disease”, “gluten intolerance” 
and “low birth weight” both individually and in combination with each other. The 
search was then limited to studies including only human subjects, the English 
language and full text articles published since the year 1999. The initial limited 
search resulted in a total of 38 articles. Duplicate articles, phone interviews and 
conference topics or review abstracts were then excluded.  The included studies 
were further limited to those looking specifically at undiagnosed maternal celiac 
disease and birth weight.  This resulted in a total of 3 studies, all of which were 
included in this systematic review. Of these studies, each was conducted in a 
different European country, Spain, Sweden and Denmark. The final studies 
included and reviewed in this paper were one case-control, prospective study 
and two population based cohort studies.  
 
RESULTS  
Sanchez et al., (2008) published a case-controlled, prospective study 
which looked at undiagnosed maternal CD and risk of low birth weight infants in 
Cabuenes Hospital.  The study was conducted over a three year period from 
2003-2005 in Austuias, a town in northern Spain. In total the authors studied 
1103 women between the ages of 15-49. Of these, 577 women were assigned to 
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the case group and 526 women in the control group. The case group was 
comprised of mothers with infants weighing less than 2,500g at birth, whereas 
mothers with infants weighing more than 2,500g were assigned to the control 
group. All women in both the case and control group were interviewed and 
provided a blood sample for serological evaluation using the Celikey Tissue 
Transglutaminase IgA antibody Assay and Anti-Endomisium antibodies.  If the 
serologic tests were positive, a duodenal biopsy was done to confirm the 
diagnosis of CD.  
             Sanchez et al. (2008) did not identify any significant age or 
origin/ethnicity difference between women the case and control groups. The 
mean age of the mothers in both groups was 31.1 years old (95%CI: 30.9-31.5). 
The authors found that low birth weight and elementary maternal education 
levels were found to be associated with an odds ratio (OR) of 1.54 (95% CI 1.21-
1.96).  The study found four of the 1,103 women had positive serological 
antibodies and duodenal biopsies for CD.  Three of these four women had never 
been diagnosed with CD. The other participant diagnosed with CD had been 
diagnosed in childhood but thought she was cured and was not following a GF 
diet.  Two of the four confirmed cases of CD were in the case group; the other 
two were in the control group.  Three of the four infants born the mothers with 
undiagnosed/untreated CD were term newborns, the 4th infant was preterm. The 
authors reported the OR for low birth weight infants as 0.91 (95% CI 0.12-6.49), 
low birth weight for gestational age was 3.19 (95% CI, 0.44-22.79), and 
prematurity was 0.61 (95% CI 0.06-5.89). This case control study found that 
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there was a clinical association between mothers with CD and low birth weight 
for gestational age but that it was not statistically significant.  
The second study reviewed was performed by Khashan et al. (2009) who 
conducted a population based cohort study looking at the impact of maternal CD 
on birth weight and preterm birth. This study looked specifically at the Danish 
population using the Danish Medical Birth Register. The authors of this study 
looked at all live singleton births between January 1979 and December 2004, 
during which a total of 1,504,342 babies were born to 836, 241 mothers. Study 
outcomes measured included low birth weight, small for gestational age (birth 
weight <10th percentile), very small for gestational age (birth weight <5th 
percentile) and preterm births. Mothers with CD were identified through the 
Danish National Hospital Register if they had received a diagnosis of CD during 
any hospitalization or outpatient care. The women included in the study were 
placed into three different groups depending on the timing of their diagnosis of 
CD;  Untreated (women who received the diagnosis after giving birth), treated 
(women who were diagnosed >90 days prior to date of gestation or date of 
delivery minus gestational age) and women without CD.  
The authors discovered 1, 563,322 births recorded between 1979-2004; 
58, 331 were excluded due to invalid birth weight or gestational age,  29 were 
excluded due to the timing of maternal CD diagnosis (<90 days date of gestation) 
and 620 were excluded due to fathers with confirmed or diagnosed CD. Infants 
born between 1 Jan 1973 and 31 December 1978 were excluded from the study 
because birth weight during this time period was recorded in intervals of 250g. 
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Infant birth weights of  >5500g and <500g, birth weight >1500g and <29 weeks 
gestational age, birth weight >2800g and gestational age between 29-33 weeks 
were all considered invalid and excluded. Infants with a gestational age <23 
weeks or >44 weeks, and those with missing gestational age were also excluded 
from the study. Infants born to celiac fathers were excluded due a previous study 
that linked paternal CD to lower birth weight and shorter gestational age.  Birth 
weight from 1979-1991 was recorded in 10g intervals and after 1991 in 1g 
intervals allowing for some discrepancy between the recorded birth weights.  
Khashan et al. (2009) conducted linear regression analysis to examine 
associations between the different groups, more specifically those with treated 
CD versus those with untreated CD. The authors of the study adjusted 
categorical variables within the study population for parity, gender, maternal age, 
and maternal medical history including diabetes, hypertension, myocardial 
infarction, renal disease, year of infant birth and paternal age. The authors used 
further multiple logistic regressions for associations found involving maternal CD 
and low birth weight and looked into whether parity (nulliparous versus 
multiparous) had any effect on birth weight.  One important confounder that the 
authors tried to account for was maternal smoking which has been found in 
previous studies to have an association with low birth weight and preterm birth.  
Maternal smoking was not recorded until 1997 so the authors restricted the 
cohort until after 1997, both including and excluding mothers who smoked to see 
if there was statistical significant difference between the two.    
 During the 25 years that Khashan et al. (2009) conducted their study, 785 
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women were diagnosed with CD and gave birth to a total of 1451 infants.  Of 
these 1451 infants, 346 were born after maternal diagnosis of CD and were 
considered to be treated. The remaining 1105 infants were born prior to maternal 
diagnosis and considered untreated.  The mean birth weight of the infants born to 
treated mothers with CD was 3503g (546 infants) while the mean weight of 
infants born to untreated mothers with CD was 3354g (579 infants). 
 The authors found after using adjusted analysis that untreated CD 
reduced the mean birth weight by 100g (adjusted difference = -98 (95% Cl: -108, 
-67).  Similar results were obtained when further restricting the analysis to only 
term infants (adjusted difference = -100 (95%CI:  -132, -68). When looking at 
untreated CD in nulliparous women they found that birth weight was reduced by 
70g [adjusted difference = -70 (95% CI: -108, -31)].  In multiparous women with 
untreated CD, birth weight was reduced more than in nulliparous women at 121g 
[adjusted difference = - 121 (95% CI: -160, -82)]. When the authors restricted the 
cohort to 1997-2004 to account for maternal smoking they found that during 
those years untreated CD reduced birth weight by 130g (adjusted difference = -
130: -190, -70)]. When allowing for adjustment with maternal smoking there was 
a small variation in the results (adjusted difference = - 140 (95% CI: -200, -80)]. 
The authors did more exclusion based on the remaining confounding variables; 
diabetes, hypertension, myocardial infarction and renal disease. The data for 
these results were not reported by the authors. However, the authors did state 
that the data found did not change their conclusions. The authors did not find an 
association between treated CD and the confounders listed above; low birth 
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weight, [adjusted difference= -15 (95%: -70-41)], small for gestational age 
[adjusted OR= 1.01 (95% CI: 0.67-1.50)] or very small for gestational age infants 
[adjusted OR = 0.92 (95% CI; 0.57-1.46].   
 The authors of this cohort study looking at the Danish population 
concluded that that untreated maternal CD in pregnancy, is in fact, associated 
with low birth weight as well as increased risk of having small for gestational age 
infant or very small for gestational age infant as compared to women with treated 
CD or without CD.  
The next study reviewed was performed by Ludvigsson, Montgomery, & 
Ekbom (2006). The authors conducted a population based cohort study 
investigating the risk of adverse fetal outcomes in Sweden for mothers with CD. 
The authors used the Swedish National Board of Health and Welfare to identify 
births from 1973-2001 as well as specific maternal medical information including 
the diagnosis of CD.  Individuals included in the study were infants born between 
1973 and 2001 to women between the ages of 15-44. Over the 28 years 
reviewed and included in the study; 2078 infants were born to mothers with CD. 
Of these 2078 infants, 1149 infants were born to mothers with a diagnosis of CD 
prior to delivery and considered treated, 929 infants were born to women 
diagnosed after delivery and considered untreated and 2,822,805 infants born to 
mothers without CD. The main outcomes addressed in this study were low birth 
weight (<2500g) and very low birth weight (<1500g).  Mothers with the diagnosis 
CD prior to the birth of their baby were compared with mothers who were 
undiagnosed until after the birth of their baby. The maternal diagnosis of CD 
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came as a hospital discharge diagnosis between 1964 and 2001 and was 
identified by the authors using the Swedish National Board of Health and 
Welfare.  The authors allowed mothers to contribute more than one infant to the 
study.  
             Information included and accounted for by the researchers was 
gender/infant sex, maternal age at delivery which was further sectioned in the 
following: 15-19, 20-24, 25-29, 30-34, 35-40, and 41-44, parity, nationality, 
smoking and diabetes mellitus.  Maternal smoking status was not available until 
after 1983.   Infants with gestational age <22 weeks or >46 weeks were excluded 
as were birth weights <300g and >7000g.  
The authors used logistic regression to calculate the odd ratios and 
confidence intervals for each specific fetal outcome measured. Multivariate 
models were used to adjust for confounding factors such as gender/infant sex, 
parity, maternal age at delivery, nationality, calendar period and smoking after 
1983.  If a mother had more than one infant in the study, this too was adjusted for 
by the authors who performed additional analysis limited to 1 birth per female to 
determine any dependence of the results. The authors reported that women with 
undiagnosed CD had lower birth weight infants than women who were 
unexposed or without CD [-170g (95% CI: -215g, -127g, p<0.001)]. Women with 
diagnosed CD were also found to have lower birth weight infants as compared to 
women without CD [ -53g (95%CI -92 to -14g, P=.004)]. After adjusting for all 
measures except smoking, women with undiagnosed CD were found to have, on 
average, an infant with a birth weight of 165g lower than infants born to women 
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without CD [95% CI -200 to -129g, P<.001) and when adding in maternal 
smoking 178g lower (-178g; 95% CI: -233 to -123g P<.001). Infants born to 
women with diagnosed CD were also found to have a lower birth weight when 
compared with women without CD [adjusted birth weight difference -62g (95%CI: 
-94 to -30g, P<.001)]. When comparing infants of women with untreated CD to 
infants of women with treated CD, infants with undiagnosed CD were found to 
have lower birth weight after adjusting for all other confounding factors except 
smoking [-87g (95%CI: -154g to -20g; P<0.011)].  To take into account the effect 
maternal smoking had on the finding of low birth weight, the authors conducted 
interaction tests which found that maternal smoking in those with undiagnosed 
CD did not result in any statistically significant results for the outcomes and 
therefore, did not modify the outcomes of undiagnosed CD and low birth weight 
infants. The authors also stratified maternal smoking into two different time 
periods 1983-1993 and 1994-2001 in which they found no effect in either time 
period on undiagnosed CD and low birth weight or on other adverse fetal 
outcomes.  
The authors of this study took the information they found a step further 
and looked at the time of maternal diagnosis of CD, and the effect it had on low 
birth weight after adjusting for all factors except smoking. They found that infants 
born to women who had been diagnosed with CD 0-2 years before birth had an 
increased risk of low birth weight babies [adjusted OR 3.93; (95% CI 2.02-7.65, 
P=0.001)]. Infants born to women who had been diagnosed with CD >2-4 years 
before birth were at an increased risk of very low birth weight [adjusted OR 
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=5.02, (95% CI: 1.23-20.45, P=0.005)]. Infants born to women who had been 
diagnosed with CD >5 years before birth had no increased risk of low birth weight 
or very low birth weight infants.  The authors of this population based cohort 
study concluded that undiagnosed CD is a risk factor for low birth weight infants. 
 
DISCUSSION 
Celiac disease is becoming more recognized worldwide in areas where 
the disease is already known and there is a rise in the number of individuals 
affected. Cases of the disease are also showing up in places previously thought 
to be free of this autoimmune disease. As a result there is now more knowledge 
about the potential complications of the disease, including gestational and 
maternal complications. A list of important studies looking at these complications 
can be found in the appendix. While CD was previously thought to be present 
only in certain geographical areas, serological testing is showing that that is no 
longer the case. As a result, the complications of CD are present in areas where 
most people are unaware of the disease itself. With the wide range of symptoms 
(asymptomatic to severe) present with the disease, some individuals who have 
CD may know they have it but chose not to follow a GF diet due to the 
inconvenience and limitations associated with it. Others may choose to cheat and 
only eat gluten some of the time, unaware of the lasting damage this causes. In 
cases such as these it is important that they are aware of the gestational and 
obstetrical complications the disease can have on them and their unborn child.  
In women with undiagnosed CD, these complications are harder to prevent 
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without screening everyone for the disease, however, it may prompt providers to 
look at CD as a possible cause for adverse fetal outcomes in patients where a 
cause is unknown.  
The studies, one case control and two population based cohorts, reviewed 
and appraised in this paper looked at three different geographical locations in 
Europe; Spain, Denmark and Sweden. Each of these studies investigated 
undiagnosed CD and birth weight which was further divided into low birth weight 
and very low birth weight. While there are other fetal outcomes addressed in 
these studies, this review is focused only on birth weight.  Combined, these three 
studies looked at over 53 years worth of medical records and over 3 million 
women who gave birth to 4, 328, 250 infants during that time. The outcome 
addressed in this paper, low birth weight and very low birth and the studies that 
provided information on these outcomes will be evaluated for quality and strength 
according to the GRADE Working Group.  
 
Study Limitations 
 There were limitations in each of the three studies reviewed and need to 
be addressed as the limitations affect the overall quality of the outcomes and 
factor into the GRADE assigned to the outcomes. 
The first study reviewed was a case control published by Sanchez et al., 
(2008). There were several limitation to this study, one being that, although the 
authors made some effort the cases and control groups were not successfully 
matched. There was the small size of the study and limited geographical location. 
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The time over which the study took place was also very short, lasting only three 
years.  In addition to the above limitation the participants could chose whether or 
not they wanted to participate and the medical history was obtained directly from 
the individual themselves not from documented medical records, which might 
result in reporting bias.  There were three doctors who conducted the interviews, 
while the authors mention they were trained in homogenous criteria; they do not 
provide any specific questions designed prior to the study allowing for bias to be 
measured. Of the four infants born to mothers with undiagnosed/untreated CD, 
three of them were term and one was preterm. Although the authors report this 
information, they do not provide information to which of the two groups, case or 
control, the infants belonged. This information is relevant to the study as preterm 
birth has been found in other studies to be a risk factor associated with CD 
(Behrman, Kliegman, & Jenson, 2000; Ludvigsson & Ludvigsson, 2001). 
The next study reviewed was the Danish cohort published by Khashan et 
al., (2009). One limitation was that once the diagnosis of CD was received, the 
authors considered the patients to be treated and assumed that individuals 
diagnosed with CD were following a GF diet. This is not always the case and a 
diagnosis of CD as with any disease does not ensure compliance with treatment, 
in this case a GF diet.  Another limitation was the database used to compile the 
information used, looked only at inpatient cases. This would subsequently 
exclude any patient who received a diagnosis of CD in a family or private 
practice. The database was started in 1977 and any patients receiving a 
diagnosis of CD prior to 1977 were unknown to the authors. Therefore, any 
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patient with a diagnosis prior to that date who gave birth during the study period 
would be incorrectly classified as belonging to the group of mothers without CD. 
Smoking a known cause of low birth weight infants might also present a limitation 
and might not have been correctly accounted for since information pertaining to 
maternal smoking was not recorded until 1997. One further limitation is that 
although it was a large study with a long duration the study was limited to the 
Danish population which is a predominantly white Scandinavian country in 
Europe where CD is thought to be most common. 
The final study reviewed was a Swedish cohort published by Ludvigsson, 
Montgomery and Ekbom (2006). The limitations in the study were similar to those 
found in the Danish cohort. The first was that as in the Danish cohort once the 
diagnosis of CD was received, the authors considered the patients to be treated 
and that they were following a GF diet. Another limitation was the national 
databases used to compile the information used by the authors which looked at 
inpatient cases. This would subsequently exclude any patient who received a 
diagnosis of CD outside an inpatient facility. The authors thought this seemed 
unlikely as a surgical biopsy is needed for confirmation of CD and must be done 
on an inpatient. In addition, women who received the diagnosis of CD did so 
because they had symptoms of the disease and the diagnosis was not done 
through screening. This may further increase the number of women with 
undiagnosed CD, as some may be asymptomatic or not seeking treatment for 
their symptoms.  Smoking, a known cause of low birth weight infants might also 
present a limitation, since there is a strong stigma associated with maternal 
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smoking, some mothers may not have admitted to smoking. While the authors 
did not find a remarkable change in results when adjusting for maternal smoking, 
this may not be completely accurate if information had been withheld.  
 
GRADE EVALUATION 
GRADE (Grading of Recommendations Assessment, Development and 
Evaluation), is a grading tool designed by the GRADE Working Group designed 
in 2000 to provide a more thorough and standardized method for grading the 
evidence and strength of recommendations provided in medical literature. 
Depending on the study design a study is given a starting grade. Randomized 
control trials are given a starting grade of high, observational studies are given a 
starting grade of low and all other studies are given a starting grade of very low. 
Studies given a starting grade of high can only be downgraded and studies 
starting with a grade of low or very low can only be upgraded. There are specific 
results and categories according to which a study can be downgraded or 
upgraded. A study can be downgraded according to study quality, consistency, 
directness, precision, publication bias and upgraded by large magnitude, dose 
response and confounders. By using a standardized grading tool accuracy, bias, 
and other shortcomings in studies are better addressed (Guyatt et al., 2008).  
As a case-control study the starting grade for the study is low for both 
outcomes addressed, low birth weight and very low birth weight.  Since the study 
is a case-control with a starting grade of low, it cannot be decreased further and 
can only increase its grade. The three areas in which the study can increase its 
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GRADE are large magnitude, dose-response and confounders. In this study 
looking at the designated outcomes there was no large magnitude found and 
there was no dose-response, as it was not applicable to this study. Some 
confounders were addressed by the authors including that of maternal smoking 
but they were not accounted specifically in both the case and control group for 
enough to warrant an increase the initial GRADE.  
  The Danish population based cohort study received a starting GRADE of 
low and therefore, was not further downgraded. The study was upgraded for its 
large magnitude of association between low birth weight and undiagnosed CD. 
The study looked at information collected over 25 years using several databases 
to account for all the information obtained and used in the study. Healthcare in 
Denmark is also free and therefore the decreases but does not eliminate 
socioeconomic bias that might potentially influence the association and 
magnitude of the study. The study was upgraded for the confounders which were 
accounted for by the authors conducting the study. The authors ran adjusted 
odds ratios, linear and multivariable regression analysis to account for these 
confounders and the impact they might have on the studied outcomes. These 
confounders included maternal smoking, co-morbidities, parity, birth year, 
gestational age and gender. The authors reported that after adjusting for these 
cofounders there was little effect on their reported findings.   
The starting GRADE for the Swedish population based cohort study was 
low and was not downgraded. The study received an increase in GRADE based 
on its large magnitude. The study included a very large population and was 
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conducted over 25 years giving credibility to the association found, and limiting 
any particular trends that might weigh too heavily on the findings. The study also 
received an increase in GRADE based on its confounders which were 
adequately addressed and accounted for by the authors. The authors of this 
study performed calculation and adjusted OR to account for each of the 
confounding factors identified; smoking, age, parity, diabetes mellitus and 
number of infants included from a single mother.    
The outcomes specifically addressed in this review are, low birth weight 
and very low birth weight.  All three of the studies discussed above had an 
outcome of low birth weight. Two of the three studies reviewed here had an 
outcome of very low birth weight, the case-controlled study and the Swedish 
cohort study. The limitations of each study have already been addressed.   
The starting grade for the outcome of low birth weight was low, given the 
study designs used and evaluated in this article. The starting grade was not 
downgraded for study quality, consistency, directness, precision or publication 
bias as these downgrades are not applicable to outcomes in which the starting 
grade is low. The outcome of low birth weight was upgraded for both large 
magnitude and confounders.  The case control study did not contribute to the 
decision to upgrade the outcome given its incredibly small sample size and very 
short duration of three years as compared to the two cohort studies which, when 
combined, looked at over 50 years of information and at over three million 
mothers and their infants. Both cohort studies, reported that risk of low birth 
weight infants in undiagnosed maternal CD to be statistically significant with 
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small confidence intervals. The authors of both cohort studies also adequately 
identified and adjusted for confounders present in their data and made sure that 
the confounders did not alter the statistical significance of the outcome.  
Therefore, the GRADE of evidence for outcome given to low birth weight was a 
grade of moderate. The GRADE working group defines a grade of moderate as 
“one where further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate” (Guyatt et al., 
2008, p.924). 
 The second outcome addressed in this article also looks at birth weight; 
looking at very low birth weight in the setting of maternal CD was given a starting 
grade of low given the study designs. The starting grade was not downgraded 
given its starting grade of low. The outcome did not receive an upgrade for the 
large magnitude or dose response. The outcome was upgraded for the 
confounders which were adequately accounted for by the authors of the Swedish 
cohort study which looked at 28 years of data. The authors of this cohort did 
statistical linear regression and multivariate models to account for potential 
confounders that could affect the final outcome. The authors did not find any 
statistically significant changes in the outcome based on the identified 
confounders. The case-control study which while looking at possible confounders 
did not do a thorough identification and statistical check of all possible 
confounders and alone, would not be awarded any upgrade but given its small 
size and duration it did not prevent the outcome from receiving the upgrade. The 
GRADE of evidence for outcome given to very low birth weight is low. GRADE 
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Working Group defines a grade of low as “one in which further research is very 
likely to have an important impact on our confidence in the estimated effect and 
is likely to change the estimate” (Guyatt et al., 2008, p.924). 
The overall GRADE for evidence for undiagnosed maternal CD and low 
birth weight infants was awarded a GRADE of moderate. The decision to grade 
the overall evidence as moderate instead of low is due to the much larger study 
population looking specifically at low birth weight. As well as the fact that 
outcome of very low birth weight infants was a subset and further division of low 
birth weight. 
 
Conclusions 
There is an association between undiagnosed maternal CD and the risk of 
low birth weight infants. This presents a problem as CD continues to become 
more prevalent in modern society and many individual are living with the disease 
undiagnosed which puts them at greater risk for having lower birth weight infants 
and opens those infants up to potential health risks. The same risk, applies to 
individuals who while diagnosed, do not follow a GF diet. Many individuals with 
CD are unaware of the complications aside from the symptomatic discomfort that 
not complying with a GF diet presents.  Undiagnosed or untreated CD, presents 
a risk not only to the individual with the disease but in the case of pregnancy, 
ones offspring as well. Women with CD need to be counseled about risk of 
having a low birth weight infant if they do not follow a GF diet prior to and during 
pregnancy. 
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While the two population based cohort studies reviewed in this paper 
show a statistically significant association between undiagnosed maternal CD 
and low birth weight infants, further similar studies are needed to strengthen this 
association. Since all of the studies in this paper were conducted in European 
countries, their geographical location needs to be taken into account. Further 
studies looking at similar outcomes in other areas such as South America, Asia 
or Africa would lend further validity to these findings. This would allow for further 
understanding of the role geographic location plays in CD as well as the risk that 
undiagnosed CD presents for low birth weight infants.  
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APPENDIX A 
Table 1: GRADE Table 
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APPENDIX B 
Table 2: Studies Table 
 
Important Epidemiological Studies on the Association of Undiagnosed CD 
and Birth Weight  
 
Author Publication Population Country  Conclusion 
Ciacci, C American 
Journal of 
Gastroenterology 
1996 
94 mothers 
with 
undiagnosed 
CD; 34 mothers 
with treated CD 
Italy Untreated CD 
was found to 
have LBW, 
shorter breast 
feeding and 
increased 
abortion 
Norgard American 
Journal of 
Gastroenterology 
1999 
127 women 
with CD 
Demark Untreated CD 
shown to have 
higher risk of 
LBW and IUGR 
Martinelli GUT 
2000 
845 women, 12 
with CD 
Italy Unfavorable 
gestation 
Ludvigsson 
JF  
GUT 
2001 
10,500 mothers 
and fathers; 53 
mothers with 
CD,  27 fathers 
Sweden Parental CD; a 
higher risk of 
LBW 
Greco L GUT 
2004 
5,000 women Italy No association 
between CD 
and LBW 
Ludvigsson 
JF  
GUT 
2005 
2078 women 
with CD 
Sweden Undiagnosed 
CD is a risk 
factor for 
adverse fetal 
outcome 
including LBW 
Salvatore S American 
Journal of 
Gastroenterology 
2007  
1,714 LBW and 
premature 
babies 
Italy LBW is higher 
in Coeliac than 
general 
population 
Khashan AS Human 
Reproduction 
2009 
1,504,342 
babies born to 
836,241 
mothers 
Sweden Undiagnosed 
CD increases 
risk of LBW, 
SGA, VSGA 
and preterm 
birth 
Sanchez, C Pediatrics 
2008 
1103 women, 
4 with CD 
Spain No 
association 
between CD 
and LBW 
Sanchez et al., 2008 
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APPENDIX C 
Figure 1: Abbreviations  
 
 
List of Abbreviations  
CD………..…………………………………………….Celiac Disease 
CI……………………………………………………….Confidence Interval 
GF..........................................................................Gluten Free 
IUGR……………………………………………………Intrauterine Growth                 
                                                                                Restriction 
 
LBW…….………………………………………………Low Birth Weight 
PTB…………………………………………................Preterm Birth  
SGA…………………………………………………….Small for Gestational Age 
VLBW…………………………………………………..Very Low Birth Weight 
 
VSGA…………………………………………………..Very Small for Gestational  
                                                                                Age 
 
 
